Clinical Trials Browser

Phase 2 × Cholangiocarcinoma × Immunotherapy × Clear all

NCT04333927 2020-06-23

ACCORD

Phase 2 Unknown

Gastrointestinal

Biliary Tract Neoplasms, Gallbladder Neoplasms, Cholangiocarcinoma

NCT04413734 2020-06-04

Combination of Anti-PD-1 Antibody and Chemotherapy for Unresectable Intrahepatic Cholangiocarcinoma

Phase 2 Unknown

Gastrointestinal

Cholangiocarcinoma